Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
temozolomide (temodar) (2 trials)
vigabatrin (sabril) (2 trials)
Trials (4 total)
Trial APIs (2 total)